<DOC>
	<DOCNO>NCT02822729</DOCNO>
	<brief_summary>The purpose study evaluate long-term safety intraocular pressure-lowering efficacy DE-117 ophthalmic solution monotherapy concomitant use DE-117 ophthalmic solution timolol ophthalmic solution 0.5 % patient open angle glaucoma ocular hypertension .</brief_summary>
	<brief_title>A Long-term Study DE-117 Ophthalmic Solution Monotherapy Concomitant Use DE-117 Ophthalmic Solution With Timolol Ophthalmic Solution Patients With OAG OH : RENGE Study</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Patients open angle glaucoma ocular hypertension Patients risk progression visual field loss Patients severe visual field defect Patients diseases preclude participation study safety reason</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>